Memorial Sloan Kettering Cancer Center Commack: Clinical Trials at Commack

Browse our continually updated listing of clinical trials available to patients at Memorial Sloan Kettering Cancer Center Commack below. You can also explore our complete listing of clinical trials available at Memorial Sloan Kettering.

Showing 21 - 40 of 110 trials
Title Investigatorsort icon Disease(s)
A Pilot Trial of Enoxaparin versus Aspirin in Patients with Cancer and Stroke
[Protocol 12-264]
De Angelis, Lisa
  • Solid Tumors
A Phase III Study of BKM120 with Fulvestrant in Postmenopausal Women with Locally Advanced or Metastatic Hormone Receptor-Positive HER2-Negative Breast Cancer
[Protocol 12-290]
Dickler, Maura
  • Breast Cancer
A Phase II Study of Fulvestrant Alone or with GDC-0941 or GDC-0980 in Women with Advanced Breast Cancer Resistant to Aromatase Inhibitor Therapy
[Protocol 12-029]
Dickler, Maura
  • Breast Cancer
A Phase II Study of MLN8237 in Advanced or Metastatic Sarcoma
[Protocol 12-194]
Dickson, Mark
  • Sarcomas
    • Soft Tissue Sarcoma
A Phase II Study of Cabozantinib in Patients with Advanced Non-Small Cell Lung Cancer
[Protocol 12-097]
Drilon, Alexander
  • Lung Cancer
  • Lung Cancer, Non-Small Cell
    • Lung Adenocarcinoma
A Phase III Study of Neo-Adjuvant Docetaxel and Androgen Deprivation Prior to Radical Prostatectomy versus Immediate Radical Prostatectomy in Patients with High-Risk, Clinically Localized Prostate Cancer
[Protocol 07-041]
Eastham, James
  • Prostate Cancer
    • Localized Disease
Cabozantinib versus Sunitinib for Treating Previously Untreated Locally Advanced or Metastatic Renal Cell Cancer
[Protocol 14-072]
Feldman, Darren
  • Kidney Cancer
A Phase II Study of Paclitaxel/Ifosfamide/Cisplatin versus Bleomycin/Etoposide/Cisplatin in Patients Newly Diagnosed with Advanced Germ Cell Tumors
[Protocol 13-074]
Feldman, Darren
  • Germ Cell Tumors
A Phase I-II Study of Dasatinib plus Paclitaxel in Patients with Metastatic Breast Cancer
[Protocol 08-122]
Fornier, Monica
  • Breast Cancer
A Phase II Study of Minimally Invasive Surgery Followed by Radiation and Chemotherapy versus Higher Dose Radiation and Chemotherapy for Patients with HPV-Negative Oropharynx Cancer
Relapsed/Refractory
[Protocol 14-038]
Ganly, Ian
  • Head & Neck Cancer
A Phase II Study of Chemotherapy and Chemoradiation Followed by Surgery or Non-Operative Management in Patients with Stage II or III Rectal Cancer
[Protocol 13-213]
Garcia-Aguilar, Julio
  • Colorectal Cancer
    • Rectal Cancer
A Phase II Study Assessing PET/CT Scanning to Guide Radiation Treatment for Inoperable Stage III Non-Small Cell Lung Cancer
[Protocol 14-032]
Gelblum, Daphna
  • Lung Cancer, Non-Small Cell
A Phase I Study of ABT-199 in Patients with Relapsed or Refractory Chronic Lymphocytic Leukemia or Non-Hodgkin Lymphoma
Relapsed/Refractory
[Protocol 11-152]
Gerecitano, John
  • Leukemia
    • Chronic Lymphocytic Leukemia
  • Lymphoma
    • Non-Hodgkin's Lymphoma
A Phase I/II Study of Cabozantinib (XL184) in Patients with Recurrent or Persistent Myeloma
Relapsed/Refractory
[Protocol 12-240]
Giralt, Sergio
  • Hematology
    • Multiple Myeloma
A Long-Term Study of Sexual and Reproductive Health in Women with Breast Cancer and Lymphoma
[Protocol 12-249]
Goldfarb, Shari
  • Breast Cancer
  • Lymphoma
    • Hodgkin's Disease
    • Non-Hodgkin's Lymphoma
  • Survivorship
A Phase III Trial Evaluating Both Erlotinib and Chemoradiation as Adjuvant Treatment for Patients with Resected Pancreatic Cancer
[Protocol 10-083]
Goodman, Karyn
  • Hepatobiliary
    • Pancreatic Cancer
  • Upper Gastrointestinal
    • Pancreatic Cancer
A Phase I Study of High-Dose-Rate Brachytherapy plus Chemotherapy in Patients with Recurrent Rectal or Anal Cancer
Newly Diagnosed & Relapsed/Refractory
[Protocol 14-104]
Goodman, Karyn
  • Colorectal Cancer
    • Rectal Cancer
A Phase II Study of Enzalutamide in Patients with Advanced or Recurrent Androgen Receptor-Positive Ovarian Cancer
[Protocol 13-119]
Grisham, Rachel
  • Ovarian Cancer
A Phase II Study of Brentuximab (SGN-35) Given Before and After Adriamycin, Vinblastine, and Dacarbazine Therapy in Older Adults with Untreated Hodgkin Lymphoma
[Protocol 11-201]
Hamlin, Paul
  • Lymphoma
    • Hodgkin's Disease
Ofatumumab with or without Bendamustine for Patients with Mantle Cell Lymphoma Who Cannot Have an Autologous Stem Cell Transplant
Newly Diagnosed
[Protocol 11-050]
Hamlin, Paul
  • Lymphoma
    • Non-Hodgkin's Lymphoma